ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3010% above fair value
$7.31−0.40 (-5.19%)
Close on Nov 19, 2026Market cap $234.32MP/E –Yield –
ClearPoint Neuro free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
ClearPoint Neuro's free cash flow for the twelve months ending Sep 30, 2026 was -$48.18M. For fiscal 2025 it was -$24.42M. The highest annual figure on record is -$2.86M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$24.42M | – |
| FY2024 | Dec 31, 2024 | -$9.23M | – |
| FY2023 | Dec 31, 2023 | -$14.44M | – |
| FY2022 | Dec 31, 2022 | -$16.42M | – |
| FY2021 | Dec 31, 2021 | -$12.87M | – |
| FY2020 | Dec 31, 2020 | -$7.85M | – |
| FY2019 | Dec 31, 2019 | -$2.86M | – |
| FY2018 | Dec 31, 2018 | -$4.69M | – |
| FY2017 | Dec 31, 2017 | -$6.02M | – |
| FY2016 | Dec 31, 2016 | -$5.92M | – |
| FY2015 | Dec 31, 2015 | -$8.71M | – |
| FY2014 | Dec 31, 2014 | -$7.30M | – |
| FY2013 | Dec 31, 2013 | -$7.85M | – |
| FY2012 | Dec 31, 2012 | -$7.56M | – |
| FY2011 | Dec 31, 2011 | -$6.27M | – |
| FY2010 | Dec 31, 2010 | -$7.77M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$20.24M | – |
| Q2 FY2026 | Jun 30, 2026 | -$7.23M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.61M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.10M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.32M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.64M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.36M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.51M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.21M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.67M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.84M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.19M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.03M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.40M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.82M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.10M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.92M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.06M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.34M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.59M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.42M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.68M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.17M | – |
| Q4 FY2019 | Dec 31, 2019 | -$466.11K | – |
| Q4 FY2018 | Dec 31, 2018 | -$583.22K | – |
| Q3 FY2018 | Sep 30, 2018 | -$986.42K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.14M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.98M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.75M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.70M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.11M | – |
See a number that looks wrong?